Difference between revisions of "Quell relief"

From HCE Wiki - The Human Cognitive Enhancement Wiki
Jump to: navigation, search
(Important Dates: info update)
(info updated)
Line 23: Line 23:
 
<tr>
 
<tr>
 
<th scope="row">Announced</th>
 
<th scope="row">Announced</th>
<td>[[Announced in::###]]</td>
+
<td>[[Announced in::Oct 2015]]</td>
 
</tr>
 
</tr>
  
 
<tr>
 
<tr>
 
<th scope="row">Released</th>
 
<th scope="row">Released</th>
<td>Developers: [[Released for developers in::###]]
+
<td>Consumers: [[Released for consumers::2015]]</td>
<br/>Consumers: [[Released for consumers::2015]]</td>
+
 
</tr>
 
</tr>
  

Revision as of 12:54, 20 October 2015

QUELL RELIEF
Quell.jpg
Category Therapeutic wearables
Developer NeuroMetrix
Announced Oct 2015
Released Consumers: 2015
Price 249 USD
Weight 62 g
Dimensions 98 x 74 x 11 mm
Controls smartphone
Standalone[1]
https://www.quellrelief.com/product


Main characteristics

Purpose

Company & People

Important Dates

1965 - Melzack and Wall proposed first conceptual model for mechanism which could lead to pain relief

1970s - Developement of TENS (Transcutaneous electrical nerve stimulation)

Ethical Issues

Health Risks

No health risks are known. Usage is 100% drug free, with clearance by FDA (Food and Drug Administration)

Enhancement/Therapy/Treatment

Quell wearable device has primarily therapeutical function. It was developed on purpose to palliate chronical pain which basically has origin in these four diseases:

Public & Media Impact and Presentation

Public Policy

Related Technologies, Project or Scientific Research

References

  1. Shows if the device is a standalone wearable computer or if it needs to be connected to a processing unit to function.